Seller navigates turbulence to net $30m in Bloomage sale
Yong Rong Global Excellence Fund managed to navigate choppy conditions in Asia’s equity capital markets to exit Bloomage Biotechnology in a HK$231.5m ($30m) block on Monday, July 13, wooing investors eager to take a position in the company at discounted levels.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts